Figure 4.

DOOR partial credit analysis. Scenario A represents a patient who values only survival (equivalent to a mortality outcome). Scenario B represents a patient who places more value on minimizing complications and would not accept any undesirable event. Scenario C represents a patient who places significant value on survival but balances this with wanting to avoid some complications. For each scenario, the mean of the partial credits scores is calculated for each treatment group and then the difference between groups is obtained. A difference with a 95% CI that overlaps zero indicates no significant difference between groups. Abbreviations: CI, confidence interval; DOR, doripenem; DOOR, desirability of outcome ranking; FDC, cefiderocol; FOS, fosfomycin; IMP, imipenem-cilastatin; LVX, levofloxacin; NA, not applicable; TZP, piperacillin/tazobactam.